PEPTO BISMOL ULTRA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Jan 2025)
What this means for you
Registered since 19 Jun 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Jun 2028: the §8 & §9 renewal).
Record
- Serial number
- 87554591
- Registration number
- 5499427
- Mark type
- Word mark
- Filed
- 03 Aug 2017
- Published for opposition
- 10 Oct 2017
- Registered
- 19 Jun 2018
- Next maintenance filing
- §8 & §9 renewal, due by 19 Jun 2028 (grace period to 19 Dec 2028)
- Attorney of record
- Jason J. Camp
Goods and services
- Class 005 — Pharmaceuticals: treatment preparations for gastro-intestinal disorders; treatment preparations to support gastro-intestinal health
Owner
- The Procter & Gamble Company, Cincinnati, OH, US
- The Procter & Gamble Company, Cincinnati, OH, US
- The Procter & Gamble Company, Cincinnati, OH, US
Prior registrations
Prosecution history
- 04 Feb 2025 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 13 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jan 2025 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 30 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 27 Jun 2024 — TEAS SECTION 7 REQUEST RECEIVED
- 19 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 17 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 May 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Apr 2018 — USE AMENDMENT FILED
- 16 May 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Apr 2018 — TEAS STATEMENT OF USE RECEIVED